PSUs and largecap stocks account for 80% of the portfolio, says Dimensions Corp Finance CEO.

By studying the brain in a dish and rat brains together, scientists at NCBS hope to understand autism and, by extension, other disorders of...

The perception that India-made drugs are of “bad quality” is largely due to many related and unrelated convergence of events.

"I think it is wholly reasonable for a country that is having a tremendous growth with challenges has to think about pricing," Witty said.

Dr Reddy’s has launched in the US mkt ropinirole hydrochloride XR (extended release) tablets used to treat the signs & symptoms of Parkinso...

Dr Reddy's Laboratories has launched in the US market Ropinirole Hydrochloride XR (extended release) tablets used to treat the signs and sy...

Shares of Glenmark Pharmaceuticals were being quoted at Rs 326 apiece in afternoon trade on the BSE today, down 1.69%.

Over the long term, if you like the stock, the valuations, and the expected growth over the next one year at least, if not more, just go ah...

Various companies of the Anil Dhirubhai Ambani Group, Mukesh Ambani-led RIL and others have moved the SC challenging the recovery of entry ...

GSKCH managing director Zubair Ahmed shares how the company leveraged its pharma parentage, acquisition plans, etc.

Recently, there has been a spurt in mergers & acquisitions (M&As) of foreign companies by Indian entities.

Chandigarh based Checkmate International has the distinction of making chess pieces for Gary Kasparov’s signature brand and for upmarket re...

GlaxoSmithKline was the drug industry’s top advertiser last year, promoting its asthma and diabetes treatments to patients and doctors. Inf...

Dr Reddy's Laboratories has announced the appointment of Dr Rajinder Kumar as its president (R&D and commercialization).

It is now the Nusli Wadia-led Britannia’s turn for a global play. The Rs 1,735-crore bakery major is scouting for a significant global acqu...

Drug makers who charge hefty margins will soon have to admit that.

CENTRE'S north-east industrial policy (NEIP) is set for an overhaul owing to indictment by the CAG and the Planning Commission's disinclina...